University of Illinois at Chicago
Announcement of an Exempt Purchase
Advanced Accelerator Applications USA IncMelburn, NJ
- Amount: An estimated $500,000
- Terms: An estimated start date of 8/15/2022 through 8/14/2025
- Renewals: None
0 BEP vendors
0 VBP vendors
0 Small businesses
The University award process may be delayed up to thirty days as this award goes through a state approval process.
First published Thursday, August 11, 2022
The University awarded a contract for Supply of Radiopharmaceuticals.
This radiopharmaceutical LUTATHERA (lutetium Lu 177 dotatate) injection is indicated for the treatment of somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs), including foregut, midgut and hindgut neuroendocrine tumors in adults.
This purchase is exempt from the usual selection processes of the Procurement Code because the procurement expenditure is for medical supplies or medical services necessary for the delivery of care and treatment at medical, dental, or veterinary teaching facilities utilized by SIU or U of I (30 ILCS 500 / 1-13(b-5)) Without this radiopharmaceutical, UIH will not be able to provide care for the patients.
For instructions on how to obtain a comprehensive purchase description, disclosure or contract forms, contact:
The State of Illinois has a policy to encourage prospective vendors to hire
qualified veterans, minorities, females, persons with disabilities and ex-offenders.